TABLE 6.
Haematological locally derived ranges from our study compared with sources from other studies.
| Parameters | Our study | Ghana11 | Togo7 | Kenya15 | France12 |
|---|---|---|---|---|---|
| Haemoglobin (g/L) | |||||
| Male | 110.00–160.00 (135.00) | 113.00–164.00 (139.00) | 100.00–184.00 (151) | 114.00–169.00 (14.2) | 134.00–167.00 |
| Female | 98.90–137.00 (114.00) | 88.00–144.00 (123.00) | 103.00–171.00 (130) | 80.00–142.00 (121.0) | 115.00–149.00 |
| Red blood cells (×1012/L) | |||||
| Male | 4.00–5.90 (4.87) | 3.79–5.96 (4.84) | 3.30–6.40 (5.0) | 4.30–6.50 (5.3) | 4.53–5.79 |
| Female | 3.40–5.30 (4.11) | 3.09.00–5.30 (4.32) | 3.10–6.00 (4.5) | 3.40–5.70 (4.5) | 4.01–5.19 |
| Haematocrit (%) | |||||
| Male | 34.60–47.61 (41.80) | 33.2–50.5 (42.20) | 28.00–54.00 (42.8) | 32.60–51.50 (41.7) | 39.20–48.60 |
| Female | 29.70–42.00 (35.61) | 26.4–45.0 (36.90) | 28.00–47.00 (38.1) | 23.20–44.30 (35.8) | 34.40–43.90 |
| MCH (pg) | |||||
| Male | 22.80–33.40 (28.20) | 22.7–33.5 (29.10) | 26.00–36.00 (29.7) | NA | 27.30–32.80 |
| Female | 23.22–31.20 (28.10) | 22.3–33.6 (28.40) | 25.00–37.00 (29.3) | NA | 24.40–32.10 |
| MCHC (g/L) | |||||
| Male | 299.00–353.00 (323.00) | 306.00–360.00 (331.00) | 290.00–390.00 (351.0) | NA | 324.00–363.00 |
| Female | 300.00–342.00 (321.00) | 304.00–365.00 (331.00) | 300.00–410.00 (351.0) | NA | 319.00–358.00 |
| MCV (fL) | |||||
| Male | 70.00–97.00 (86.00) | 70.00–98.00 (88.00) | 80.00–99.00 (85.0) | 55.00–98.00 (80.0) | 79.60–94.00 |
| Female | 72.00–96.00 (87.00) | 73.00–96.00 (86.00) | 80.00–95.00 (84.0) | 60.00–94.00 (79.0) | 74.70–94.20 |
| Reticulocytes (×109/L) | |||||
| Male | 30.00–250.00 (60.00) | NA | NA | NA | NA |
| Female | 20.00–177.00 (40.00) | NA | NA | NA | NA |
| Platelets (×109/L) | |||||
| Male | 133.00–339.00 (211.00) | 88.00–352.00 (208.00) | 120.00–443.00 (239.0) | 102.00–307.00 (201.0) | 172.00–398.00 |
| Female | 143.00–369.00 (243.00) | 89.00–408.00 (224.00) | 150.00–436.00 (247.0) | 88.00–439.00 (220.0) | 185.00–445.00 |
| White blood cell (×109/L) | |||||
| Male | 2.60–6.81 (4.10) | 3.50–9.20 (5.50) | 1.90–10.10 (4.1) | 2.50–7.40 (5.3) | 4.09–11.00 |
| Female | 2.80–6.70 (4.60) | 3.40–9.30 (5.30) | 2.20–7.80 (4.2) | 3.30–9.70 (5.6) | 4.02–11.40 |
| Neutrophils (×109/L) | |||||
| Male | 0.92–3.00 (1.60) | 1.50–5.90 (2.70) | 0.50–5.40 (1.6) | 0.80–3.90 (2.0) | 1.78–6.90 |
| Female | 1.01–3.53 (1.98) | 1.40–5.50 (2.70) | 0.50–4.40 (1.6) | 1.30–3.80 (2.3) | 1.75–7.50 |
| Eosinophils (×109/L) | |||||
| Male | 0.05–0.98 (0.20) | NA | 0.00–0.05 (0.2) | 0.10–1.70 (0.5) | 0.048–0.59 |
| Female | 0.12–0.42 (0.15) | NA | 0.00–0.05 (0.2) | 0.10–1.30 (0.4) | 0.041–0.55 |
| Lymphocytes (×109/L) | |||||
| Male | 1.03–3.13 (1.71) | 1.20–5.20 (2.20) | 1.10–4.03 (2.1) | 1.00–3.50 (2.2) | 1.34–3.91 |
| Female | 1.06–2.90 (1.89) | 1.20–4.40 (2.10) | 1.20–4.30 (2.2) | 1.30–3.80 (2.2) | 1.24–3.56 |
| Monocytes (×109/L) | |||||
| Male | 0.11–0.54 (0.26) | 0.20–1.40 (0.50) | 0.05–0.80 (0.2) | 0.20–0.90 (0.5) | 0.22–0.77 |
| Female | 0.14–0.65 (0.32) | 0.20–0.90 (0.40) | 0.05–0.80 (0.2) | 0.30–0.80 (0.5) | 0.20–0.71 |
| Basophils (×109/L) | |||||
| Male | 0.03–0.22 (0.08) | NA | NA | 0.01–0.19 (0.04) | 0.00–0.097 |
| Female | 0.03–0.29 (0.08) | NA | NA | 0.00–0.20 (0.04) | 0.00–0.085 |
| Population | |||||
| Blood Donors | |||||
| Male (n) | 161 | - | 1047 | - | - |
| Female (n) | 133 | - | 302 | - | - |
| Urban | |||||
| Male (n) | - | 316 | - | - | - |
| Female (n) | - | 308 | - | - | - |
| Rural | |||||
| Male (n) | - | - | - | 77 | - |
| Female (n) | - | - | - | 83 | - |
| National | |||||
| Male (n) | - | - | - | - | 19 393 |
| Female (n) | - | - | - | - | 13 526 |
Note: Reference ranges, 2.5% – 97.5%.
MCHC, corpuscular haemoglobin concentration; MCH, haemoglobin concentration; MCV, corpuscular volume; NA, not available (median values).